Despite a strong Piotroski F-Score of 7/9 and extreme valuation discounts (Graham Number $3.39 vs Price $0.51), NCI exhibits the classic characteristics of a value trap. The company is experiencing a catastrophic price collapse, with a 91.8% decline in the last month and a 98.9% loss over five years. While earnings are growing and ROE is positive, the 24% YoY revenue contraction and total lack of technical momentum suggest a fundamental breakdown in market confidence that outweighs the deterministic value metrics.